No evidence suggests harm, but definitive evidence of long-term safety does not exist either
Second, the respective study populations were quite different, with STEP 1 including a younger, healthier population with more women (73.1% of the semaglutide arm in STEP 1 versus 27.7% in SELECT) and higher mean BMI (37.8 kg m 2 versus 33.3 kg m 2 , respectively) 14,21
Research-grade peptides are not approved for human use
(Source: Chemist4U) 48% of people said they gained more respect or attention since starting the medication, while 4% reported only negative treatment
B., et al.(2024)
So, and that leads into my, um, bigger program if people are interested, but the first, Four part series is free to everybody and they can find it on my website or if you have the link there in your show notes